Agentic AI for Mid-Sized Pharma
Run governed, AI-driven trials with the throughput of a top-20 sponsor.
Mid-sized pharma teams operate with lean internal capacity, heavy CRO dependence, and fixed milestone pressure across multiple programs.
Maxis AI provides a supervised execution layer that strengthens internal capability — improving biometrics throughput, predictability, and oversight without expanding contractor spend.
Human-in-the-loop validation · Audit traceability
Our platform strengthens execution across critical workflows.
Study Startup Coordination
- Faster site activation readiness
- Improved startup tracking visibility
Clinical Data Management
- Automated data cleaning and validation
- Reduced manual reconciliation effort
Statistical Programming Support
- Improved biometrics efficiency
- Automated dataset preparation
Portfolio Oversight
- Continuous monitoring across trials
- Earlier detection of execution risks
Where Mid-Sized Pharma Execution Slows
Execution gaps commonly occur due to:
Heavy reliance on CRO partners
Limited internal biometrics capacity
Delayed database readiness timelines
Fragmented operational visibility
Small teams managing large portfolios
What Improves with Agentic AI
With Agentic AI for mid-sized pharma, execution becomes structured and predictable.
Faster database readiness and submission timelines
Improved biometrics efficiency without contractor expansion
Earlier detection of risks across programs
Stronger execution visibility across CRO and in-house workflows
Improved milestone predictability
Recommended Approach
Deploy the AI Workforce across data management and statistical programming workflows first — the highest capacity constraints. Organizations that do this recover 40–50% of database lock time without expanding teams.
12 FTEs. 15 Trials. No Contractors. DB Lock Accelerated 40–50%.
80% manual query effort. SAP cycles stretched to 4–8 weeks. See how a mid-sized pharma scaled biometrics execution without adding headcount.
15 Trials
Managed by 12 FTEs
60–70%
Queries auto resolved
40–50%
Faster DB lock
0
Contractors hired
All You Need to Know
It embeds supervised execution across biometrics and clinical workflows, improving readiness visibility and throughput consistency.
It allows execution capacity to scale independently of biometrics staffing while maintaining governance controls.
Through unified portfolio oversight, traceable workflows, and structured supervision thresholds.
Biometrics efficiency, governance visibility, and database readiness timelines.
By coordinating structured workflows under governance controls, improving execution predictability across regions and partners.
Explore the Agentic AI Platform.
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.